Last Updated on June 22, 2023

Drug Development and Registration- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Center of Pharmaceutical Analytics

Abbreviation: Drug Dev. Regist.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

0.74

SJR

 0.191

h-Index

 5

Rank

 19643

Important Details

Title Drug Development and Registration
Standard Abbreviation Drug Dev. Regist.
Type of Publication Journal
Discipline Pharmaceutical Science (Q3); Drug Discovery (Q4)
Impact Score 0.74
SCImago Journal Rank (SJR) 0.191
h-index 5
Overall Rank 19643
Publisher Name Center of Pharmaceutical Analytics
Publication Country Russian Federation
International Standard Serial Number (ISSN) 26585049, 23052066
Coverage and History 2020-2022
Best Quartile Q3
Total Citations Received
(Last 3 Year)
157

About Drug Development and Registration


Drug Development and Registration is a journal published by Center of Pharmaceutical Analytics. This journal covers the area[s] related to Pharmaceutical Science, Drug Discovery, etc. The coverage history of this journal is as follows: 2020-2022. The rank of this journal is 19643. This journal's impact score, h-index, and SJR are 0.74, 5, and 0.191, respectively. The ISSN of this journal is/are as follows: 26585049, 23052066.

The best quartile of Drug Development and Registration is Q3. This journal has received a total of 157 citations during the last three years (Preceding 2022).


Drug Development and Registration Impact Score 2022-2023


The latest impact score (IS) of the Drug Development and Registration is 0.74. It is computed in the year 2023 as per its definition and based on Scopus data. 0.74

It is decreased by a factor of around 0.01, and the percentage change is -1.33% compared to the preceding year 2021, indicating a falling trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Drug Development and Registration Impact Score 2023


Impact Score 2022 of Drug Development and Registration is 0.74. If a similar downward trend continues, IS may decrease in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Drug Development and Registration. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 0.74
2021 0.75
2020 0.29
2019 0.00

Drug Development and Registration h-index


  Table Setting

The h-index of Drug Development and Registration is 5. By definition of the h-index, this journal has at least 5 published articles with more than 5 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Drug Development and Registration ISSN


The International Standard Serial Number (ISSN) of Drug Development and Registration is/are as follows: 26585049, 23052066.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Drug Development and Registration Ranking and SCImago Journal Rank (SJR)


The Drug Development and Registration is ranked 19643 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.191.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Drug Development and Registration Publisher


Table Setting

The publisher of Drug Development and Registration is Center of Pharmaceutical Analytics. The publishing house of this journal is located in the Russian Federation. Its coverage history is as follows: 2020-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Drug Development and Registration is Drug Dev. Regist.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Drug Dev. Regist.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Drug Development and Registration


If your area of research or discipline is related to Pharmaceutical Science, Drug Discovery, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Drug Development and Registration?

The latest impact score of Drug Development and Registration is 0.74. It is computed in the year 2023.


What is the h-index of Drug Development and Registration?

The latest h-index of Drug Development and Registration is 5. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Drug Development and Registration?

The latest SCImago Journal Rank (SJR) of Drug Development and Registration is 0.191. It is calculated in the year 2023.


What is the ranking of Drug Development and Registration?

The latest ranking of Drug Development and Registration is 19643. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Drug Development and Registration?

Drug Development and Registration is published by Center of Pharmaceutical Analytics. The publication country of this journal is Russian Federation.


What is the abbreviation of Drug Development and Registration?

This standard abbreviation of Drug Development and Registration is Drug Dev. Regist..


Is "Drug Development and Registration" a Journal, Conference or Book Series?

Drug Development and Registration is a journal published by Center of Pharmaceutical Analytics.


What is the scope of Drug Development and Registration?

The scope of Drug Development and Registration is as follows:

  • Pharmaceutical Science
  • Drug Discovery

For detailed scope of Drug Development and Registration, check the official website of this journal.


What is the ISSN of Drug Development and Registration?

The International Standard Serial Number (ISSN) of Drug Development and Registration is/are as follows: 26585049, 23052066.


What is the best quartile for Drug Development and Registration?

The best quartile for Drug Development and Registration is Q3.


What is the coverage history of Drug Development and Registration?

The coverage history of Drug Development and Registration is as follows 2020-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Dermatologia Kliniczna Journal Cornetis 25442 7 0.00
Entrepreneurship Theory and Practice Journal Wiley-Blackwell 338 185 12.75
World Englishes Journal Wiley-Blackwell 4960 60 1.97
Abacus Journal Wiley-Blackwell Publishing Ltd 8398 49 2.52
Journal of Education and Work Journal Brill Academic Publishers 9268 43 1.93
Korean Journal of Applied Microbiology and Biotechnology Journal Korean Society for Applied Microbiology 22033 0 0.00
Epigenetics Journal Landes Bioscience 2362 105 4.11
Transactions on Embedded Computing Systems Journal Association for Computing Machinery (ACM) 6019 61 2.25
Asian Nursing Research Journal Elsevier BV 7629 35 2.31
International Journal of Advertising Journal Taylor and Francis Ltd. 1226 74 8.22

Check complete list




Drug Development and Registration Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 0.74
2021 0.75
2020 0.29
2019 0.00



Top Journals/Conferences in Pharmaceutical Science

Nano Today
Elsevier | Netherlands

Advanced Drug Delivery Reviews
Elsevier | Netherlands

Advanced healthcare materials
John Wiley and Sons Ltd | United Kingdom

Journal of Controlled Release
Elsevier | Netherlands

Bioengineering and Translational Medicine
John Wiley & Sons Inc. | United States

Apoptosis : an international journal on programmed cell death
Springer Netherlands | Netherlands

Journal of Nanobiotechnology
BioMed Central Ltd. | United Kingdom

Asian Journal of Pharmaceutical Sciences
Shenyang Pharmaceutical University | China

Journal of Pharmaceutical Analysis
Xi'an Jiaotong University | China

Bioconjugate Chemistry
American Chemical Society | United States

Phytomedicine
Urban und Fischer Verlag Jena | Germany

International Journal of Nanomedicine
Dove Medical Press Ltd. | New Zealand

Statistics in Biopharmaceutical Research
Taylor and Francis Ltd. | United Kingdom

Advanced Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

Expert Opinion on Drug Delivery
Taylor and Francis Ltd. | United Kingdom

See All

Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Protein and Cell
Higher Education Press | China

Emerging Microbes and Infections
Taylor and Francis Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Molecular Therapy - Nucleic Acids
Cell Press | United States

Journal of Medicinal Chemistry
American Chemical Society | United States

Antibodies
MDPI AG | Switzerland

Vaccines
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

Expert Opinion on Therapeutic Targets
Taylor and Francis Ltd. | United Kingdom

Nucleic Acid Therapeutics
Mary Ann Liebert Inc. | United States

Drug Discovery Today
Elsevier Ltd. | United Kingdom

Current Opinion in Systems Biology
Elsevier Ltd. | United Kingdom

See All